{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T08:07:38Z","timestamp":1768723658130,"version":"3.49.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2008,10,15]],"date-time":"2008-10-15T00:00:00Z","timestamp":1224028800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1007\/s00213-008-1350-1","type":"journal-article","created":{"date-parts":[[2008,10,14]],"date-time":"2008-10-14T04:43:47Z","timestamp":1223959427000},"page":"453-459","source":"Crossref","is-referenced-by-count":10,"title":["Effects of sibutramine and rimonabant in rats trained to discriminate between 22- and 2-h food deprivation"],"prefix":"10.1007","volume":"203","author":[{"given":"David C.","family":"Jewett","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas W.","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Travis R.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Britta L.","family":"Fiksdal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason M.","family":"Wiebelhaus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew R.","family":"Dunbar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine R.","family":"Filtz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noah L.","family":"Novinska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allen S.","family":"Levine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,10,15]]},"reference":[{"key":"1350_CR1","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s002130050326","volume":"132","author":"M Arnone","year":"1997","unstructured":"Arnone M, Maruani J, Chaperon F, Thiebot MH, Poncelet M, Soubrie P, Le Fur G (1997) Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors. Psychopharmacology (Berl) 132:104\u2013106","journal-title":"Psychopharmacology (Berl)"},{"key":"1350_CR2","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1038\/sj.bjp.0704030","volume":"132","author":"M Brown","year":"2001","unstructured":"Brown M, Bing C, King P, Pickavance L, Heal D, Wilding J (2001) Sibutramine reduces feeding, body fat and improves insulin resistance in dietary\u2013obese male Wistar rats independently of hypothalamic neuropeptide Y. Br J Pharmacol 132:1898\u20131904","journal-title":"Br J Pharmacol"},{"key":"1350_CR3","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/0278-5846(88)90003-6","volume":"12","author":"WR Buckett","year":"1988","unstructured":"Buckett WR, Thomas PC, Luscombe GP (1988) The pharmacology of sibutramine hydrochloride (BTS 54 524), a new antidepressant which induces rapid noradrenergic down-regulation. Prog Neuropsychopharmacol Biol Psychiatry 12:575\u2013584","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"1350_CR4","doi-asserted-by":"crossref","first-page":"PL113","DOI":"10.1016\/S0024-3205(98)00322-1","volume":"63","author":"G Colombo","year":"1998","unstructured":"Colombo G, Agabio R, Diaz G, Lobina C, Reali R, Gessa GL (1998) Appetite suppression and weight loss after the cannabinoid antagonist SR 141716. Life Sci 63:PL113\u2013PL117","journal-title":"Life Sci"},{"key":"1350_CR5","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/S0022-3565(25)13038-3","volume":"253","author":"RL Corwin","year":"1990","unstructured":"Corwin RL, Woolverton WL, Schuster CR (1990) Effects of cholecystokinin, d-amphetamine and fenfluramine in rats trained to discriminate 3 from 22\u00a0hr of food deprivation. J Pharmacol Exp Ther 253:720\u2013728","journal-title":"J Pharmacol Exp Ther"},{"key":"1350_CR6","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0022-3565(24)37090-9","volume":"283","author":"C Gundlah","year":"1997","unstructured":"Gundlah C, Martin KF, Heal DJ, Auerbach SB (1997) In vivo criteria to differentiate monoamine reuptake inhibitors from releasing agents: sibutramine is a reuptake inhibitor. J Pharmacol Exp Ther 283:581\u2013591","journal-title":"J Pharmacol Exp Ther"},{"key":"1350_CR7","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1093\/ajcn\/68.6.1180","volume":"68","author":"DL Hansen","year":"1998","unstructured":"Hansen DL, Toubro S, Stock MJ, Macdonald IA, Astrup A (1998) Thermogenic effects of sibutramine in humans. Am J Clin Nutr 68:1180\u20131186","journal-title":"Am J Clin Nutr"},{"key":"1350_CR8","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/sj.ijo.0801059","volume":"23","author":"DL Hansen","year":"1999","unstructured":"Hansen DL, Toubro S, Stock MJ, Macdonald IA, Astrup A (1999) The effect of sibutramine on energy expenditure and appetite during chronic treatment without dietary restriction. Int J Obes Relat Metab Disord 23:1016\u20131024","journal-title":"Int J Obes Relat Metab Disord"},{"key":"1350_CR9","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/sj.ijo.0801481","volume":"25","author":"D Hansen","year":"2001","unstructured":"Hansen D, Astrup A, Toubro S, Finer N, Kopelman P, Hilsted J, Rossner S, Saris W, Van Gaal L, James W, Goulder For The SSGM (2001) Predictors of weight loss and maintenance during 2 years of treatment by sibutramine in obesity. Results from the European multi-centre STORM trial. Sibutramine Trial of Obesity Reduction and Maintenance. Int J Obes Relat Metab Disord 25:496\u2013501","journal-title":"Int J Obes Relat Metab Disord"},{"key":"1350_CR10","first-page":"70","volume":"9","author":"HM Heshmati","year":"2001","unstructured":"Heshmati HM, Caplain H, Bellisle F (2001) SR141716, a selective cannabinoid CB1 receptor antagonist reduces hunger, caloric intake, and body weight in overweight or obese men. Obes Res 9:70","journal-title":"Obes Res"},{"key":"1350_CR11","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1038\/sj.bjp.0701311","volume":"121","author":"HC Jackson","year":"1997","unstructured":"Jackson HC, Bearham MC, Hutchins LJ, Mazurkiewicz SE, Needham AM, Heal DJ (1997a) Investigation of the mechanisms underlying the hypophagic effects of the 5-HT and noradrenaline reuptake inhibitor, sibutramine, in the rat. Br J Pharmacol 121:1613\u20131618","journal-title":"Br J Pharmacol"},{"key":"1350_CR12","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1038\/sj.bjp.0701312","volume":"121","author":"HC Jackson","year":"1997","unstructured":"Jackson HC, Needham AM, Hutchins LJ, Mazurkiewicz SE, Heal DJ (1997b) Comparison of the effects of sibutramine and other monoamine reuptake inhibitors on food intake in the rat. Br J Pharmacol 121:1758\u20131762","journal-title":"Br J Pharmacol"},{"key":"1350_CR13","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s002130100730","volume":"156","author":"TU J\u00e4rbe","year":"2001","unstructured":"J\u00e4rbe TU, Lamb RJ, Lin S, Makriyannis A (2001) (R)-methanandamide and Delta 9-THC as discriminative stimuli in rats: tests with the cannabinoid antagonist SR-141716 and the endogenous ligand anandamide. Psychopharmacology (Berl) 156:369\u2013380","journal-title":"Psychopharmacology (Berl)"},{"key":"1350_CR14","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s00213-004-1916-5","volume":"177","author":"TU J\u00e4rbe","year":"2004","unstructured":"J\u00e4rbe TU, Harris MY, Li C, Liu Q, Makriyannis A (2004) Discriminative stimulus effects in rats of SR-141716 (rimonabant), a cannabinoid CB1 receptor antagonist. Psychopharmacology (Berl) 177:35\u201345","journal-title":"Psychopharmacology (Berl)"},{"key":"1350_CR15","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s00213-008-1076-0","volume":"198","author":"TU J\u00e4rbe","year":"2008","unstructured":"J\u00e4rbe TU, Li C, Vadivel SK, Makriyannis A (2008) Discriminative stimulus effects of the cannabinoid CB1 receptor antagonist rimonabant in rats. Psychopharmacology (Berl) 198:467\u2013478","journal-title":"Psychopharmacology (Berl)"},{"key":"1350_CR16","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1097\/01.wnr.0000215767.94528.fb","volume":"17","author":"DC Jewett","year":"2006","unstructured":"Jewett DC, Lefever TW, Flashinski DP, Koffarnus MN, Cameron CR, Hehli DJ, Grace MK, Levine AS (2006) Intraparaventricular neuropeptide Y and ghrelin induce learned behaviors that report food deprivation in rats. NeuroReport 17:733\u2013737","journal-title":"NeuroReport"},{"key":"1350_CR17","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1345\/aph.18319","volume":"33","author":"CA Luque","year":"1999","unstructured":"Luque CA, Rey JA (1999) Sibutramine: a serotonin-norepinephrine reuptake-inhibitor for the treatment of obesity. Ann Pharmacother 33:968\u2013978","journal-title":"Ann Pharmacother"},{"key":"1350_CR18","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0014-2999(02)01423-1","volume":"440","author":"CA Luque","year":"2002","unstructured":"Luque CA, Rey JA (2002) The discovery and status of sibutramine as an anti-obesity drug. Eur J Pharmacol 440:119\u2013128","journal-title":"Eur J Pharmacol"},{"key":"1350_CR19","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/BF02247436","volume":"124","author":"RS Mansbach","year":"1996","unstructured":"Mansbach RS, Rovetti CC, Winston EN, Lowe JA III (1996) Effects of the cannabinoid CB1 receptor antagonist SR141716A on the behavior of pigeons and rats. Psychopharmacology (Berl) 124:315\u2013322","journal-title":"Psychopharmacology (Berl)"},{"key":"1350_CR20","doi-asserted-by":"crossref","first-page":"R67","DOI":"10.1152\/ajpregu.00150.2008","volume":"295","author":"CM Mathes","year":"2008","unstructured":"Mathes CM, Ferrara M, Rowland NE (2008) Cannabinoid CB1 receptor antagonists reduce caloric intake by decreasing palatable diet selection in a novel dessert protocol in female rats. Am J Physiol Regul Integr Comp Physiol 295:R67\u2013R75","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"1350_CR21","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.neulet.2007.04.012","volume":"419","author":"T Melis","year":"2007","unstructured":"Melis T, Succu S, Sanna F, Boi A, Argiolas A, Melis MR (2007) The cannabinoid antagonist SR 141716A (Rimonabant) reduces the increase of extra-cellular dopamine release in the rat nucleus accumbens induced by a novel high palatable food. Neurosci Lett 419:231\u2013235","journal-title":"Neurosci Lett"},{"key":"1350_CR22","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1001\/jama.295.13.1549","volume":"295","author":"CL Ogden","year":"2006","unstructured":"Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM (2006) Prevalence of overweight and obesity in the United States, 1999\u20132004. JAMA 295:1549\u20131555","journal-title":"JAMA"},{"key":"1350_CR23","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1001\/jama.295.7.761","volume":"295","author":"FX Pi-Sunyer","year":"2006","unstructured":"Pi-Sunyer FX, Aronne LJ, Heshmati HM, Devin J, Rosenstock J (2006) Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial. JAMA 295:761\u2013775","journal-title":"JAMA"},{"key":"1350_CR24","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/0014-5793(94)00773-X","volume":"350","author":"M Rinaldi-Carmona","year":"1994","unstructured":"Rinaldi-Carmona M, Barth F, Heaulme M, Shire D, Calandra B, Congy C, Martinez S, Maruani J, Neliat G, Caput D (1994) SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett 350:240\u2013244","journal-title":"FEBS Lett"},{"key":"1350_CR25","first-page":"179","volume":"9","author":"J Simiand","year":"1998","unstructured":"Simiand J, Keane M, Keane PE, Soubrie P (1998) SR 141716, a CB1 cannabinoid receptor antagonist, selectively reduces sweet food intake in marmoset. Behav Pharmacol 9:179\u2013181","journal-title":"Behav Pharmacol"},{"key":"1350_CR26","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/clpt.1991.144","volume":"50","author":"M Weintraub","year":"1991","unstructured":"Weintraub M, Rubio A, Golik A, Byrne L, Scheinbaum ML (1991) Sibutramine in weight control: a dose-ranging, efficacy study. Clin Pharmacol Ther 50:330\u2013337","journal-title":"Clin Pharmacol Ther"},{"key":"1350_CR27","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/0028-3908(95)00027-4","volume":"34","author":"JL Wiley","year":"1995","unstructured":"Wiley JL, Barrett RL, Lowe J, Balster RL, Martin BR (1995a) Discriminative stimulus effects of CP 55,940 and structurally dissimilar cannabinoids in rats. Neuropharmacology 34:669\u2013676","journal-title":"Neuropharmacology"},{"key":"1350_CR28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-3565(25)12022-3","volume":"275","author":"JL Wiley","year":"1995","unstructured":"Wiley JL, Lowe JA, Balster RL, Martin BR (1995b) Antagonism of the discriminative stimulus effects of delta 9-tetrahydrocannabinol in rats and rhesus monkeys. J Pharmacol Exp Ther 275:1\u20136","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-008-1350-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-008-1350-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-008-1350-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T18:59:05Z","timestamp":1738436345000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-008-1350-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10,15]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["1350"],"URL":"https:\/\/doi.org\/10.1007\/s00213-008-1350-1","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,10,15]]}}}